| scholarly article | Q13442814 |
| P2093 | author name string | Ju Hee Oh | |
| Na Kyung Lee | |||
| P2860 | cites work | Bone metabolism in type 2 diabetes mellitus | Q78095348 |
| v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation | Q79383955 | ||
| Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1 | Q22306225 | ||
| Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition | Q24629773 | ||
| Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 | ||
| Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
| Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells | Q28506839 | ||
| Osteoclast differentiation and activation | Q29547556 | ||
| Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
| Insulin enhances RANKL-induced osteoclastogenesis via ERK1/2 activation and induction of NFATc1 and Atp6v0d2. | Q33361435 | ||
| Therapeutic approaches to bone diseases | Q34021178 | ||
| Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism | Q34021680 | ||
| Gene expression profiling in osteoclast precursors by insulin using microarray analysis | Q34628262 | ||
| Control of osteoblast function and regulation of bone mass | Q35128237 | ||
| Obatoclax regulates the proliferation and fusion of osteoclast precursors through the inhibition of ERK activation by RANKL | Q35188522 | ||
| Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues | Q36281802 | ||
| Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis | Q36636165 | ||
| Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis | Q36739991 | ||
| RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 | ||
| Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover | Q37176385 | ||
| NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). | Q37302319 | ||
| Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG-63 cells | Q39697564 | ||
| Fra-1 replaces c-Fos-dependent functions in mice | Q40445308 | ||
| Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. | Q40594156 | ||
| Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. | Q42826784 | ||
| Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus | Q44075415 | ||
| RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II. | Q46628325 | ||
| Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. | Q50678899 | ||
| Up-regulation of cyclinD1 and Bcl2A1 by insulin is involved in osteoclast proliferation. | Q53031373 | ||
| Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. | Q53941037 | ||
| Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation | Q57675158 | ||
| Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology | Q73958624 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 371-377 | |
| P577 | publication date | 2017-05-22 | |
| P1433 | published in | Molecules and Cells | Q12623193 |
| P1476 | title | Up-Regulation of RANK Expression via ERK1/2 by Insulin Contributes to the Enhancement of Osteoclast Differentiation | |
| P478 | volume | 40 |
Search more.